{"id":"https://openalex.org/W4400569371","doi":"https://doi.org/10.3389/fendo.2024.1396161","title":"Association between neutrophil-to-lymphocyte ratio and diabetic retinopathy in patients with type 2 diabetes: a cohort study","display_name":"Association between neutrophil-to-lymphocyte ratio and diabetic retinopathy in patients with type 2 diabetes: a cohort study","publication_year":2024,"publication_date":"2024-07-11","ids":{"openalex":"https://openalex.org/W4400569371","doi":"https://doi.org/10.3389/fendo.2024.1396161","pmid":"https://pubmed.ncbi.nlm.nih.gov/39055056","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11269086"},"language":"en","primary_location":{"id":"doi:10.3389/fendo.2024.1396161","doi":"https://doi.org/10.3389/fendo.2024.1396161","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2024.1396161","pdf_url":null,"source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fendo.2024.1396161","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078429626","display_name":"Yuchen Tang","orcid":"https://orcid.org/0000-0002-5635-6319","observed_orcids":["https://orcid.org/0000-0002-5635-6319"]},"institutions":[{"id":"https://openalex.org/I4210153915","display_name":"Ningbo University Affiliated Hospital","ror":"https://ror.org/045rymn14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153915"]},{"id":"https://openalex.org/I4210166261","display_name":"Ningbo First Hospital","ror":"https://ror.org/05pkzpg75","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166261"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yuchen Tang","raw_affiliation_strings":["Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China","institution_ids":["https://openalex.org/I4210153915","https://openalex.org/I4210166261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100360974","display_name":"Li Li","orcid":"https://orcid.org/0000-0001-5585-743X","observed_orcids":["https://orcid.org/0000-0001-5585-743X"]},"institutions":[{"id":"https://openalex.org/I4210153915","display_name":"Ningbo University Affiliated Hospital","ror":"https://ror.org/045rymn14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153915"]},{"id":"https://openalex.org/I4210166261","display_name":"Ningbo First Hospital","ror":"https://ror.org/05pkzpg75","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166261"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Li Li","raw_affiliation_strings":["Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China","institution_ids":["https://openalex.org/I4210153915","https://openalex.org/I4210166261"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108050246","display_name":"Jialin Li","orcid":"https://orcid.org/0000-0001-6930-9530","observed_orcids":["https://orcid.org/0000-0001-6930-9530"]},"institutions":[{"id":"https://openalex.org/I4210153915","display_name":"Ningbo University Affiliated Hospital","ror":"https://ror.org/045rymn14","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153915"]},{"id":"https://openalex.org/I4210166261","display_name":"Ningbo First Hospital","ror":"https://ror.org/05pkzpg75","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166261"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jialin Li","raw_affiliation_strings":["Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Endocrinology and Metabolism, The First Affiliated Hospital of Ningbo University, Ningbo, China","institution_ids":["https://openalex.org/I4210153915","https://openalex.org/I4210166261"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108050246"],"corresponding_institution_ids":["https://openalex.org/I4210153915","https://openalex.org/I4210166261"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":3.2324,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.94152573,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"15","issue":null,"first_page":"1396161","last_page":"1396161"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.7768999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.7768999934196472,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.1868000030517578,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.996999979019165},{"id":"https://openalex.org/keywords/diabetic-retinopathy","display_name":"diabetic retinopathy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.9470000267028809},{"id":"https://openalex.org/keywords/chronic-inflammation","display_name":"chronic inflammation","score":0.8769999742507935},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.891443133354187},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7264644503593445},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7257275581359863},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.5879479646682739},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.5738554000854492},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5523697137832642},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.533694863319397},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5188152194023132},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.511081337928772},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4829539656639099},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43312615156173706},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4328618049621582},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.41246289014816284},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.41127437353134155},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.25306522846221924},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.15041449666023254}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002681","descriptor_name":"China","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009504","descriptor_name":"Neutrophils","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018655","descriptor_name":"Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fendo.2024.1396161","doi":"https://doi.org/10.3389/fendo.2024.1396161","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2024.1396161","pdf_url":null,"source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11269086","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11269086","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11269086/pdf/fendo-15-1396161.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Endocrinol (Lausanne)","raw_type":"Text"},{"id":"pmid:39055056","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39055056","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in endocrinology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:11e0653c58b140e4ae912d22874b40aa","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/11e0653c58b140e4ae912d22874b40aa","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Endocrinology, Vol 15 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fendo.2024.1396161","doi":"https://doi.org/10.3389/fendo.2024.1396161","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fendo.2024.1396161","pdf_url":null,"source":{"id":"https://openalex.org/S2597401208","display_name":"Frontiers in Endocrinology","issn_l":"1664-2392","issn":["1664-2392"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Endocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322605","display_name":"Ningbo University","ror":"https://ror.org/03et85d35"},{"id":"https://openalex.org/F4320338469","display_name":"Science and Technology Program of Zhejiang Province","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400569371.pdf","grobid_xml":"https://content.openalex.org/works/W4400569371.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W104053609","https://openalex.org/W1966206262","https://openalex.org/W1967562661","https://openalex.org/W2027064096","https://openalex.org/W2042689611","https://openalex.org/W2045147004","https://openalex.org/W2129365186","https://openalex.org/W2138480916","https://openalex.org/W2155965977","https://openalex.org/W2156121263","https://openalex.org/W2594717408","https://openalex.org/W2607031541","https://openalex.org/W2610377281","https://openalex.org/W2735102204","https://openalex.org/W2769611366","https://openalex.org/W2809489644","https://openalex.org/W2888814360","https://openalex.org/W2894836649","https://openalex.org/W2909413843","https://openalex.org/W3013925481","https://openalex.org/W3042330797","https://openalex.org/W3088840355","https://openalex.org/W3176364966","https://openalex.org/W3184682008","https://openalex.org/W3213208314","https://openalex.org/W4288885871","https://openalex.org/W4306731659","https://openalex.org/W4322718850","https://openalex.org/W4382501861","https://openalex.org/W4384662655","https://openalex.org/W4387163961","https://openalex.org/W4388979056","https://openalex.org/W4389571995"],"related_works":["https://openalex.org/W4292080973","https://openalex.org/W7122836430","https://openalex.org/W3034552272","https://openalex.org/W1967562661","https://openalex.org/W3150712366","https://openalex.org/W4309750229","https://openalex.org/W3005128881","https://openalex.org/W4415026825","https://openalex.org/W3038556289","https://openalex.org/W3139394079"],"abstract_inverted_index":{"Background:":[0],"Chronic":[1],"inflammation":[2,21],"is":[3,16],"implicated":[4],"in":[5,52,80,182,236],"the":[6,33,46,118,123,184,221],"development":[7],"of":[8,19,58,133],"diabetic":[9,29],"retinopathy":[10],"(DR).":[11],"The":[12,140],"neutrophil-to-lymphocyte":[13],"ratio":[14,143],"(NLR)":[15],"a":[17,77,130,205],"marker":[18],"systemic":[20],"that":[22,204,232],"has":[23,220],"been":[24],"linked":[25],"to":[26,116,223],"cardiovascular":[27],"and":[28,37,50,74,103,107,122,156,171,228],"kidney":[30],"diseases.":[31],"However,":[32],"link":[34],"between":[35,48,72,120],"NLR":[36,49,121,150,207,219],"DR":[38,51,69,147,187],"remains":[39],"unclear.":[40],"As":[41],"such,":[42],"this":[43],"study":[44],"investigated":[45],"association":[47,119],"Chinese":[53],"patients.":[54],"Method:":[55],"A":[56],"total":[57],"857":[59],"adults":[60],"diagnosed":[61],"with":[62,212],"type":[63],"2":[64],"diabetes":[65],"mellitus":[66],"(T2DM)":[67],"without":[68],"at":[70,208],"baseline":[71,209],"2018":[73],"2021,":[75],"from":[76],"single":[78],"center":[79],"Ningbo,":[81],"China,":[82],"were":[83,105,159],"included.":[84],"Baseline":[85],"clinical":[86,230],"data,":[87],"including":[88],"age,":[89],"sex,":[90],"T2DM":[91],"duration,":[92],"hypertension,":[93],"smoking,":[94],"drinking,":[95],"glycated":[96],"hemoglobin":[97],"level,":[98],"lipid":[99],"profile,":[100],"renal":[101],"function,":[102],"NLR,":[104,183],"recorded":[106],"analyzed.":[108],"Cox":[109],"proportional":[110],"hazard":[111,142],"regression":[112],"analysis":[113],"was":[114,210],"used":[115],"assess":[117],"risk":[124,185,215],"for":[125,145,186,198,216],"incident":[126,146,217],"DR.":[127,139,218],"Results:":[128],"During":[129],"median":[131],"follow-up":[132],"3.0":[134],"years,":[135],"140":[136],"patients":[137],"developed":[138],"multivariable-adjusted":[141],"(HR)":[144],"across":[148],"ascending":[149],"quartiles":[151],"(\u22641.46":[152],"[reference],":[153],"1.47-1.90,":[154],"1.91-2.45":[155],">":[157],"2.45)":[158],"1.000,":[160],"1.327":[161],"(95%":[162,168,173],"confidence":[163],"interval":[164],"[CI]":[165],"0.754-2.334),":[166],"1.555":[167],"CI":[169,174,194],"0.913-2.648)":[170],"2.217":[172],"1.348-3.649),":[175],"respectively.":[176],"For":[177],"each":[178],"1-standard":[179],"deviation":[180],"increase":[181],"increased":[188,214],"by":[189],"29.2%":[190],"(HR":[191],"1.292":[192],"[95%":[193],"1.112-1.501)":[195],"after":[196],"adjusting":[197],"confounding":[199],"factors.":[200],"Conclusion:":[201],"Results":[202],"revealed":[203],"higher":[206],"associated":[211],"an":[213,225],"potential":[222],"be":[224],"inexpensive,":[226],"reliable,":[227],"valuable":[229],"measure":[231],"merits":[233],"further":[234],"exploration":[235],"future":[237],"studies.":[238]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-07-12T00:00:00"}